399 related articles for article (PubMed ID: 30617121)
1. Development of a Universal Influenza Vaccine.
Estrada LD; Schultz-Cherry S
J Immunol; 2019 Jan; 202(2):392-398. PubMed ID: 30617121
[TBL] [Abstract][Full Text] [Related]
2. The Pathway to a Universal Influenza Vaccine.
Paules CI; Marston HD; Eisinger RW; Baltimore D; Fauci AS
Immunity; 2017 Oct; 47(4):599-603. PubMed ID: 29045889
[TBL] [Abstract][Full Text] [Related]
3. A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
Erbelding EJ; Post DJ; Stemmy EJ; Roberts PC; Augustine AD; Ferguson S; Paules CI; Graham BS; Fauci AS
J Infect Dis; 2018 Jul; 218(3):347-354. PubMed ID: 29506129
[TBL] [Abstract][Full Text] [Related]
4. How far have we reached in development of effective influenza vaccine?
Looi QH; Foo JB; Lim MT; Le CF; Show PL
Int Rev Immunol; 2018; 37(5):266-276. PubMed ID: 30252547
[TBL] [Abstract][Full Text] [Related]
5. Future epidemiological and economic impacts of universal influenza vaccines.
Sah P; Alfaro-Murillo JA; Fitzpatrick MC; Neuzil KM; Meyers LA; Singer BH; Galvani AP
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20786-20792. PubMed ID: 31548402
[TBL] [Abstract][Full Text] [Related]
6. Epitope-focused vaccine design against influenza A and B viruses.
Ren H; Zhou P
Curr Opin Immunol; 2016 Oct; 42():83-90. PubMed ID: 27343703
[TBL] [Abstract][Full Text] [Related]
7. Intanza 15 μg intradermal seasonal influenza vaccine in older adults (aged ≥ 60 years): profile report.
Duggan ST; Plosker GL
BioDrugs; 2010 Dec; 24(6):407-9. PubMed ID: 21043547
[No Abstract] [Full Text] [Related]
8. Novel Platforms for the Development of a Universal Influenza Vaccine.
Kumar A; Meldgaard TS; Bertholet S
Front Immunol; 2018; 9():600. PubMed ID: 29628926
[TBL] [Abstract][Full Text] [Related]
9. Better, Faster, Stronger: mRNA Vaccines Show Promise for Influenza Vaccination in Older Adults.
Bartley JM; Cadar AN; Martin DE
Immunol Invest; 2021 Oct; 50(7):810-820. PubMed ID: 33830864
[TBL] [Abstract][Full Text] [Related]
10. Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs.
Dhakal S; Klein SL
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391269
[TBL] [Abstract][Full Text] [Related]
11. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
[TBL] [Abstract][Full Text] [Related]
12. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
Grohskopf LA; Blanton LH; Ferdinands JM; Chung JR; Broder KR; Talbot HK; Morgan RL; Fry AM
MMWR Recomm Rep; 2022 Aug; 71(1):1-28. PubMed ID: 36006864
[TBL] [Abstract][Full Text] [Related]
13. Changes in and shortcomings of control strategies, drug stockpiles, and vaccine development during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans.
Mei L; Song P; Tang Q; Shan K; Tobe RG; Selotlegeng L; Ali AH; Cheng Y; Xu L
Biosci Trends; 2013 Apr; 7(2):64-76. PubMed ID: 23612075
[TBL] [Abstract][Full Text] [Related]
14. Improving influenza vaccines: challenges to effective implementation.
Zhou F; Trieu MC; Davies R; Cox RJ
Curr Opin Immunol; 2018 Aug; 53():88-95. PubMed ID: 29719276
[TBL] [Abstract][Full Text] [Related]
15. Workshop report: Optimization of animal models to better predict influenza vaccine efficacy.
Lane MC; Gordon JL; Jiang C; Leitner WW; Pickett TE; Stemmy E; Bozick BA; Deckhut-Augustine A; Embry AC; Post DJ
Vaccine; 2020 Mar; 38(13):2751-2757. PubMed ID: 32145879
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for seasonal and pandemic influenza.
Nichol KL; Treanor JJ
J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
[TBL] [Abstract][Full Text] [Related]
17. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccine composition recommendation for the 1989-90 season.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1989 Mar; 38(11):183-5. PubMed ID: 2493570
[No Abstract] [Full Text] [Related]
19. Selecting and Using the Appropriate Influenza Vaccine for Each Individual.
Sekiya T; Ohno M; Nomura N; Handabile C; Shingai M; Jackson DC; Brown LE; Kida H
Viruses; 2021 May; 13(6):. PubMed ID: 34073843
[TBL] [Abstract][Full Text] [Related]
20. Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.
Zhang Y; Xu C; Zhang H; Liu GD; Xue C; Cao Y
Viruses; 2019 Apr; 11(5):. PubMed ID: 31052339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
